questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 March 2025 to Question 39290 on Coronavirus: Drugs, whether his Department has had recent discussions with the National Institute for Health and Care Excellence on the potential use of PEMGARDA to help protect clinically vulnerable people against covid-19 in emergency situations.
answerText: Ministers and Department officials have regular discussions with the National Institute for Health and Care Excellence (NICE) on a range of issues, including topics for new or updated guidance. Pemivibart, also known under the brand name Pemgarda, for use...
heading: Coronavirus: Drugs